Overview

Epiallopregnanolone (3β,5α-tetrahydroprogesterone) is the 3β-epimer of allopregnanolone. While allopregnanolone is one of the most potent GABAA enhancers (calming/sedating), epiallopregnanolone has the opposite effect - it selectively antagonizes allopregnanolone's actions.

Think of it as the "off switch" for allopregnanolone.

Chemistry: The 3α vs 3β Difference

The ONLY structural difference is the stereochemistry at the 3-position:

Compound 3-Position GABAA Effect
Allopregnanolone 3α-OH Strong positive modulator
Epiallopregnanolone 3β-OH Antagonist at neurosteroid site

This single stereochemical change completely reverses the pharmacology.

Mechanism of Action

Neurosteroid Site Antagonist

Epiallopregnanolone is a competitive antagonist at the neurosteroid site on GABAA receptors:

  • Blocks allopregnanolone binding
  • Prevents neurosteroid-induced enhancement
  • Does NOT directly inhibit GABA
  • Does NOT affect benzodiazepine or barbiturate sites

Selective Antagonism

Key point: Epiallopregnanolone only blocks neurosteroid effects:

  • ✓ Blocks allopregnanolone sedation
  • ✓ Blocks THDOC calming
  • ✗ Does NOT block benzodiazepine effects
  • ✗ Does NOT block barbiturate effects

This selectivity is pharmacologically unique.

No Intrinsic Activity

By itself, epiallopregnanolone has no effect on GABAA receptors. It only becomes active in the presence of other neurosteroids that it can antagonize.

Effects

Pheromone Effects

Epiallopregnanolone is confirmed as P102 from the Androtics Direct putative pheromones line. SteveO (PheromoneXS) identified P102 as epiallopregnanolone "with some near certainty" through personal research and development.

PheromoneXS uses epiallopregnanolone in:

  • XiSt (for men) — listed on the bottle as "EpiAlloPregnenolone," alongside androsterone, epiandrosterone, androstenone, and 3 proprietary molecules
  • XS119 / P-Bomb (for men) — contains androstenone, epiallopregnanolone, and androstenetrione in small doses

HoP classifies it as "The Survival Pheromone" based on its effects profile:

  • Very clear auditory enhancement: Notice the smallest sounds in a crisper and cleaner way. Hyper-awareness of all sights and sounds around you, triggering a feeling of being much more "tuned in" to the environment.
  • "Spotlight effect": Field of vision gets narrower as focus gets sharper. Creates staring and very noticeable attention from people. Described as "pinpoint focus" unlike broader focus molecules.
  • Visual enhancement, especially at night: Improved ability to see and focus at nighttime. A "do or die" type survival response that promotes automatic quick choices.
  • One-track-minded focus: Useful for getting tasks done. Allows focused efforts in a singular, determined way.
  • Introversion/seriousness: Can make the wearer come off quite "seriously" if not worn with social molecules.

DiscoverXS community reports:

  • Suspected to be the key molecule responsible for XiSt's imprinting effect — the association where "merely thinking about that person evokes those feelings" and "the person affected is likely to spend a lot of time thinking about you"
  • Produces "pinpoint focus" distinct from broader attention molecules
  • Can cause introversion and being "in one's head" — best combined with social molecules
  • Clarified that epi-allo is NOT responsible for the "reset" effect in XiSt (that's attributed to alpha-THDOC)

GABAA Antagonist Effects (Pharmacological)

  • Reduces sedation from allopregnanolone
  • Reduces calming from THDOC
  • May reduce "brain fog" from high neurosteroid states
  • Restores alertness

Clinical Interest

Epiallopregnanolone (as Sepranolone) is being studied for:

  • PMDD (premenstrual dysphoric disorder)
  • Conditions with excess neurosteroid sensitivity
  • Negative mood effects from progesterone metabolites

Dosage Guidelines

Limited pheromone community data. Based on research:

Level Amount
Light 5-10 mg
Moderate 25-50 mg

Notes:

  • Only useful if experiencing excess neurosteroid effects
  • No effect on its own
  • Start low to assess response
  • Not for general use

Use Cases in Pheromone Stacking

Balancing Overly Sedating Stacks

If a pheromone combination is too sedating:

  • Add epiallopregnanolone to reduce sleepiness
  • Maintains pheromone effects while reducing self-sedation
  • Useful for daytime use of normally sedating blends

Countering Excess Calming

Some users experience too much calming from:

  • High androsterone
  • High androstenol
  • Stacks with multiple GABAA modulators

Epiallopregnanolone can restore mental sharpness without removing the pheromone signaling effects.

PMDD and Cycle-Related Issues

Women experiencing negative effects from progesterone metabolites during luteal phase may benefit from epiallopregnanolone's antagonism.

Comparison to Pregnenolone Sulfate

Both counter GABAA enhancement, but differently:

Compound Mechanism Effect
Pregnenolone Sulfate GABAA antagonist + NMDA agonist Stimulating, cognitive
Epiallopregnanolone Neurosteroid site antagonist only Normalizing, not stimulating

PS adds excitation; epiallopregnanolone just removes excess sedation.

Biosynthesis

Epiallopregnanolone is produced by epimerization of allopregnanolone:

Allopregnanolone (3α-OH)
    ↓ (3α→3β hydroxysteroid epimerase)
Epiallopregnanolone (3β-OH)

This involves oxidation to the 3-ketone, then reduction to the 3β configuration.

Community Consensus

Rating: 7/10

A distinctive molecule with both pharmacological uniqueness and real pheromone community data. Used by PheromoneXS in two retail products (XiSt and XS119), confirmed as Androtics Direct P102, and characterized through both HoP testing and DiscoverXS user reports.

Strengths:

  • Used in PheromoneXS retail products (XiSt, XS119/P-Bomb)
  • Confirmed identity as Androtics Direct P102 by SteveO
  • Unique "spotlight" and "pinpoint focus" effects
  • Suspected key to XiSt's imprinting effect
  • Unique pharmacological mechanism (selective neurosteroid antagonist)
  • Multiple community data sources (HoP, DiscoverXS, PheroTruth)

Limitations:

  • Can cause introversion/seriousness without social molecules to balance
  • Pharmacologically has no intrinsic GABAA activity (only blocks other neurosteroids)
  • Specialized knowledge needed for custom blending
  • Limited single-molecule testing data (most reports are from blends)

Sources